Aptamer-Conjugated Gold Nanoparticles Targeting Human Epidermal Growth Factor Receptor 2 (HER2) for Cancer Theranostic, In Vitro Assays

Aptamer-Conjugated Gold Nanoparticles Targeting Human Epidermal Growth Factor Receptor 2 (HER2) for Cancer Theranostic, In Vitro Assays

The human epidermal growth factor receptor 2 (HER2) is a transmembrane glycoprotein overexpressed in several solid tumors, including breast and prostate cancer. HER2 has been associated with aggressiveness, a poor prognosis, resistance to therapy, and accelerated tumor growth. Recent advances in nan...

Full description

Bibliographic Details
Main Authors: Paola Y. Carrión-García, Celia N. Sánchez-Domínguez, Hugo L. Gallardo-Blanco, Elsa N. Garza-Treviño, Jesús R. Delgado-Balderas, Jorge A. Roacho-Pérez, Margarita Sánchez-Domínguez
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Materials Proceedings
Subjects:
HER2
breast cancer
nanomedicine
gold nanoparticles
aptamer
theranostics
Online Access:https://www.mdpi.com/2673-4605/14/1/25

Internet

https://www.mdpi.com/2673-4605/14/1/25

Similar Items